Uploads
Contact
/
Login
Upload
Search Results for 'Adverse Cohort'
Funding Opportunities for
myesha-ticknor
September 30, 2014
test
Cohort 2017: Succession
marina-yarberry
Linda
myesha-ticknor
Barbara Kawulich , Tamra
faustina-dinatale
ESSENTIAL TRAINING
alida-meadow
P.R.E.P Initiative P repared. R esilient. E mpowered. P
lois-ondreau
David A. Swanson (Correspondence author)
liane-varnes
Prepared by Dr. Toni Lehman
mitsue-stanley
Adaptive Population Enrichment for Oncology Trials with Tim
giovanna-bartolotta
Experimental designs
luanne-stotts
TRAINING
debby-jeon
SOF/VEL + RBV
celsa-spraggs
No randomisation
tatiana-dople
≥ 18 years, HCV genotype 1-6
karlyn-bohler
Appendix F APPENDIX F Vaccine Safety The Vaccine Adverse Event Reporting System VAERS
mitsue-stanley
SMV 150 mg
faustina-dinatale
Randomisation
pamella-moone
Comparison of NNRTI vs PI/r
alexa-scheidler
Reddy KR. Lancet Infect Dis. 2015;15:27-35
natalia-silvester
Friday, October 16, 2015
debby-jeon
September 30, 2014 Dawn Cullity
conchita-marotz
ACAP CEO Summit June 29, 2018
lindy-dunigan
Phase IB Trial of Carboxyamidotriazole Orotate
myesha-ticknor
6
7
8
9
10
11
12
13
14
15
16